San Diego, CA - Nearly 50% of patients receiving a left ventricular assist device (LVAD) experience a hospital readmission within six months of implantation, and most first-time readmissions are for ...
NOVA: What are the advantages of continuous rather than pulsatile (pulse-like) flow? Frazier: With continuous flow, there isn't a pulse. Without a pulse, it is not necessary to have volume ...
The U.S. Food and Drug Administration approved use of a heart pump on Wednesday that was largely designed and tested at the Texas Heart Institute. The HeartMate II device, a continuous-flow pump that ...
According to NPR, doctors at the Texas Heart Institute have created a device which uses ventricular assist devices (VADs) to move blood throughout the body using whirling rotors. The catch? Patients ...
With Penn State IRB approval and parental informed consent, and under the guidance of a Data Safety Medical Board (DSMB) in addition to FDA clinicaltrials.com database registration, 238 patients were ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results